SLC18A2 and diabetes mellitus: From our preliminary results, 10-(+)-11C-DTBZ could be a potential PET imaging agent for VMAT2 and could be used in the diagnosis and monitoring of VMAT2-related disorders, such as Parkinson’s disease and diabetes.